Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

v3.20.2
Stock-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 12, 2020
Aug. 01, 2020
Jul. 15, 2020
Jul. 14, 2020
Jul. 03, 2020
Aug. 04, 2019
Jul. 23, 2019
May 22, 2019
Aug. 04, 2018
Sep. 14, 2015
Jun. 20, 2007
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Jul. 02, 2020
Dec. 31, 2019
Sep. 14, 2017
Sep. 14, 2016
Stock options granted to purchase common stock, issued                           900,000          
Stock options granted to purchase common stock, outstanding                       9,050,000   9,050,000     7,850,000    
Charges to operations                         $ 5,030   $ 31,046        
Total deferred compensation expense for outstanding value of unvested stock options                           $ 980,000          
Intrinsic value of exercisable but unexercised in-the-money stock options                       $ 5,496,500   $ 5,496,500          
Fair market value, per share                           $ 1.17          
Board of Directors [Member]                                      
Number of warrants outstanding acquire common stock         1,000,000                            
Warrants term, description         September 14, 2020 to September 14, 2025                            
Closing stock price of warrants                               $ 0.90      
Collaboration Agreement [Member] | BioPharmaWorks [Member]                                      
Stock price per share                   $ 0.6707                  
Stock options fully vested amount, fair value                   $ 670,715                  
Number of warrants to purchase common stock                   1,000,000                  
Number of warrants to purchase common stock per warrant                   500,000                  
Warrant exercisable term                                   5 years 5 years
Warrants exercise price                                   $ 2.00 $ 1.00
Employment Agreement [Member] | Dr. James Miser [Member]                                      
Stock options granted to purchase common stock, issued   500,000                                  
Stock option vested exercisable term   5 years                                  
Fair value of stock options   $ 572,650                                  
Stock price per share   $ 1.1453                                  
Stock options fully vested amount, fair value   $ 143,163                                  
Stock options description   Dr. Miser was granted options for 500,000 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $1.19 per share, which was equal to the closing price of the Company's common stock on the effective date of the employment agreement. The options vested as to 25% on the effective date, and will vest 25% on each of the first, second and third anniversaries of the effective date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($1.1453 per share), of which $143,163 was attributable to the stock options fully-vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 1, 2020 through August 1, 2023. During the three months and nine months ended September 30, 2020, the Company recorded a charge to operations of $166,697 with respect to these stock options.                                  
Charges to operations                       166,697   $ 166,697          
Stock option excercise price   $ 1.19                                  
Employment Agreement [Member] | Mr. Weingarten [Member]                                      
Stock options granted to purchase common stock, issued 350,000                                    
Stock option vested exercisable term 5 years                                    
Stock options are exercisable price per share $ 1.19                                    
Fair value of stock options $ 400,855                                    
Stock price per share $ 1.1453                                    
Stock options fully vested amount, fair value $ 100,214                                    
Stock options description On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted options for 350,000 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of 5 years and an exercise price of $1.19 per share, which was equal to the closing price of our common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($1.1453 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months and nine months ended September 30, 2020, the Company recorded a charge to operations of $113,667, with respect to these stock options.                                    
Charges to operations                       113,667   113,667          
Winson Sze Chun Ho [Member]                                      
Stock options granted to purchase common stock, issued                 200,000                    
Stock option vested exercisable term                 5 years                    
Stock options are exercisable price per share                 $ 0.28                    
Number of fully vested option issued           100,000     100,000                    
Fair value of stock options                 $ 104,920                    
Stock price per share                 $ 0.2623                    
Stock options fully vested amount, fair value                 $ 101,475                    
Dr. Yun Yen [Member]                                      
Stock options granted to purchase common stock, issued               50,000 200,000                    
Stock option vested exercisable term                 5 years                    
Stock options are exercisable price per share                 $ 0.28                    
Number of fully vested option issued           100,000     100,000                    
Fair value of stock options                 $ 104,920                    
Stock price per share                 $ 0.2623                    
Stock options fully vested amount, fair value                 $ 52,460                    
Dr. Winson Sze Chun Ho, Dr. Yun Yen, Dr. Stephen Forman and Dr. Philip Palmedo [Member]                                      
Stock options granted to purchase common stock, issued               200,000                      
Stock option vested exercisable term               5 years                      
Stock options are exercisable price per share               $ 1.10                      
Stock price per share               $ 0.9453                      
Stock options fully vested amount, fair value               $ 189,060                      
Dr. Winson Sze Chun Ho [Member]                                      
Stock options granted to purchase common stock, issued               50,000                      
Dr. Stephen Forman [Member]                                      
Stock options granted to purchase common stock, issued               50,000                      
Dr. Philip Palmedo [Member]                                      
Stock options granted to purchase common stock, issued               50,000                      
Eric Forman [Member]                                      
Stock option vested exercisable term               5 years                      
Stock options are exercisable price per share               $ 1.10                      
Number of fully vested option issued               100,000                      
Stock price per share               $ 0.9453                      
Stock options fully vested amount, fair value               $ 94,525                      
Eric Forman [Member] | Employment Agreement [Member]                                      
Stock options granted to purchase common stock, issued     350,000                                
Stock option vested exercisable term     5 years                                
Stock options are exercisable price per share     $ 1.19                                
Number of fully vested option issued 100,214                                    
Fair value of stock options     $ 400,855                                
Stock price per share     $ 1.1453                                
Stock options description     On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric Forman, Mr. Forman was granted options for 350,000 shares of the Company's common stock. The options can be exercised on a cashless basis. The options have a term of 5 years and an exercise price of $1.19 per share, which was equal to the closing price of the Company's common stock on the grant date. The options vested as to 25% on August 12, 2020, and will vest 25% on each of the first, second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($1.1453 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options will be charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months and nine months ended September 30, 2020, the Company recorded a charge to operations of $113,667 with respect to these stock options.                                
Charges to operations                       $ 113,667   $ 113,667          
Mr. Johnson's [Member]                                      
Stock options granted to purchase common stock, issued             500,000                        
Stock option vested exercisable term             5 years                        
Stock options are exercisable price per share             $ 1.10                        
Stock price per share             $ 0.8680                        
Stock options fully vested amount, fair value             $ 434,024                        
2007 Stock Compensation Plan [Member]                                      
Stock options granted to purchase common stock, issued                           1,250,000          
Stock options granted to purchase common stock, outstanding                       1,250,000   1,250,000          
2007 Stock Compensation Plan [Member] | Maximum [Member]                                      
Number of restricted stock issued                     2,500,000                
2020 Stock Incentive Plan [Member] | Maximum [Member]                                      
Number of restricted stock issued       14,000,000